Methohexital
Sponsors
Varsinais-Suomen hyvinvointialue, James Murrough, Mayo Clinic, University of New Mexico, Northwell Health
Conditions
AnesthesiaAtrial FibrillationAtrial FlutterBipolar DepressionDepressionDirect Current ElectroencephalogramECTElectroconvulsive Therapy
Early Phase 1
Phase 4
Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression
CompletedNCT01881763
Start: 2010-06-30End: 2017-07-31Updated: 2023-03-09
Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion
CompletedNCT04187196
Start: 2020-04-29End: 2022-09-28Updated: 2023-11-13
Comparison of Esketamine/Propofol and Methohexital Anesthesia for ECT
CompletedNCT05655754
Start: 2022-11-01End: 2026-03-31Updated: 2026-10-07
Effects of General Anaesthetic Agents on the Efficacy of Electroconvulsive Therapy and EEG Changes in Patients with Depression
Not yet recruitingCTIS2025-524829-40-00
Target: 174Updated: 2026-09-15
Unknown Phase
Use of Ketamine to Enhance Electroconvulsive Therapy (ECT) in Depression
TerminatedNCT01309581
Start: 2010-04-30End: 2010-10-31Updated: 2013-08-30
Ketamine Anesthesia in Electroconvulsive Therapy
CompletedNCT01367119
Start: 2011-05-31End: 2012-03-31Updated: 2013-08-08
Use of Ketamine vs Methohexital for Electroconvulsive Therapy (ECT) on Patient Recovery and Re-orientation Time
CompletedNCT01567852
Start: 2011-08-31End: 2013-03-31Updated: 2014-12-30
Methohexital v Propofol as General Anesthetic in Patients on ACEIs or ARBs
CompletedNCT02624050
Start: 2016-08-01End: 2018-01-31Updated: 2025-01-28
Ketamine Anesthesia for Improvement of Depression in ECT
CompletedNCT02752724
Start: 2016-03-31End: 2018-04-30Updated: 2018-06-06